Abstract
Transient loss of consciousness is a common symptom in the general population; it is estimated that approximately 40 % individuals will faint at least once in their lifetime. Vasovagal syncope (VVS), characterized by paroxysmal reflex-mediated hypotension associated with bradycardia, is the most common of the neurally mediated syncopal syndromes. The neurally mediated vasovagal reflex is caused by a rapid increase in vagal tone, which results in bradycardia or asystole, associated with hypotension, caused by the reduction in peripheral sympathetic activity, leading to systemic vasodilation with consequent global cerebral hypoperfusion and loss of consciousness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ammirati F, Colivicchi F, Velardi A et al (2001) Prevalence and correlates of syncope related traumatic injuries in vasovagal fainters. Ital Heart J 2:38–41
Soteriades ES, Evans JC, Larson MG et al (2002) Incidence and prognosis of syncope. N Engl J Med 347:878–885
Moya A, Sutton R, Ammirati F et al (2009) Guidelines for the diagnosis and management of syncope (version 2009). The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA) and Heart Rhythm Society (HRS). Eur Heart J 30:2631–2671
Schroeder C, Bush V, Norcliffe L et al (2002) Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation 106:2806–2811
Brignole M, Croci F, Menozzi C et al (2002) Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 40:2053–2059
Krediet CT, van Dijk N, Linzer M et al (2002) Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 106:1684–1689
van Dijk N, Quartieri F, Blanc JJ et al (2006) PC-Trial Investigators. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol 48:1652–1657
Morillo CA, Leitch JW, Yee R et al (1993) A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22:1843–1848
Lee TM, Su SF, Chen MF et al (1996) Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 78:480–482
Raviele A, Brignole M, Sutton R et al (1999) Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 99:1452–1457
Brignole M, Menozzi C, Gianfranchi L et al (1992) A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 70:339–342
Madrid A, Ortega I, Rebollo GJ et al (2001) Lack of efficacy of atenolol for the prevention of neurally-mediated syncope in highly symptomatic population: a prospective double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 37:554–557
Ventura R, Maas R, Zeidler D et al (2002) A randomized and controlled pilot trial of β-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 25:816–821
Sheldon R, Connolly S, Rose S et al (2006) Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113:1164–1170
Ward CR, Gray JC, Gilroy JJ et al (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79:45–49
Perez-Lugones A, Schweikert R, Pavia S et al (2001) Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 12:935–938
Romme JJ, van Dijk N, Go-Schon IK et al (2011) Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Europace 13:1639–1647
Salim MA, Di Sessa TG (2005) Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol 45:484–488
Di Girolamo E, Di Iorio C, Sabatini P et al (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33:1227–1230
Theodorakis GN, Leftheriotis D, Livanis EG et al (2006) Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace 8:193–198
Benditt DG, Fahy GJ, Lurie KG et al (1999) Pharmacotherapy of neurally mediated syncope. Circulation 100:1242–1248
Guzman JC, Armaganijan LV, Morillo CA (2013) Treatment of neurally mediated reflex syncope. Cardiol Clin 31:123–129
Scott WA, Pongiglione G, Bromberg BI et al (1995) Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76:400–402
Sheldon R, Morillo CA, Krahn A et al (2011) A randomized clinical trial of fludrocortisone for the prevention of vasovagal syncope (POST2). Can J Cardiol 27:S335–S336
Raj SR, Faris PD, McRae M et al (2012) Rationale for the prevention of syncope trial IV: assessment of midodrine. Clin Auton Res 22:275–280
Di Girolamo E, Di Iorio C, Leonzio L et al (1999) Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 100:1798–1801
Ector H, Reybrouck T, Heidbuchel H et al (1999) Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin Electrophysiol 21:193–196
Foglia-Manzillo G, Giada G, Gaggioli G et al (2004) Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace 6:199–204
Tan MP, Newton JL, Chadwick TJ et al (2010) Home orthostatic training in vasovagal syncope modifies autonomic tone: results of a randomized, placebo-controlled pilot study. Europace 12:240–246
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ammirati, F., Danisi, N., Romano, M. (2015). Treatment of Vasovagal Syncope: Counseling, Drugs, and Counter-Pressure Maneuvers. In: Alboni, P., Furlan, R. (eds) Vasovagal Syncope. Springer, Cham. https://doi.org/10.1007/978-3-319-09102-0_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-09102-0_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09101-3
Online ISBN: 978-3-319-09102-0
eBook Packages: MedicineMedicine (R0)